Vaccines

The world urgently needs 20 billion doses of a vaccine that will protect global citizens against the coronavirus. States are throwing huge sums of public money at the race to beat Covid-19, but who will get there first? Will Big Pharma focus on private profit? Will vaccine nationalism prevail, or will the patent be shared to create a low-cost global supply?

Mayo 2020

MAIN-0-00-03-06-scaled-1100x619-1.jpg
The world urgently needs 20 billion doses of a vaccine that will protect global citizens against the coronavirus. States are throwing huge sums of public money at the race to beat Covid-19, but who will get there first? Will Big Pharma focus on private profit? Will vaccine nationalism prevail, or will the patent be shared to create a low-cost global supply?

Big Pharma, one of the most lucrative industries in the world, does not usually give priority to vaccine development, as it is financially risky and other drugs are more profitable.

The public spends billions to help with the research and development of commercial drugs, but usually only a fraction of this amount goes to fund vaccine development.

The Coronavirus has turned the tables: The stepchild of the drug industry now gets full attention – and huge public funding.

The reporters of Investigate Europe followed the public money spent on the hunt for a Covid-19 vaccine and found that most of these grants and loans are given without the necessary conditions to ensure global supply and a fair access. If too little is done to prevent “vaccine nationalism,” in the end the public will pay the price. 

Read our reports below and scroll down to read articles published in media partner outlets across Europe.

Web Exclusives

Explainer

Publicaciones

A vaccine for all may be an (expensive) chimera
A vaccine for all may be an (expensive) chimera

Público, Portugal

17 mayo 2020

Vaccini, egoismo e guerra tra gli Stati
Vaccini, egoismo e guerra tra gli Stati

Il Fatto Quotidiano, Italy

18 mayo 2020

Die Jagd nach der ersten Spritze
Die Jagd nach der ersten Spritze

Falter, Austria

20 mayo 2020

Wer bekommt den Impfstoff – und zu welchem Preis?
Wer bekommt den Impfstoff – und zu welchem Preis?

Republik, Switzerland

21 mayo 2020

Globaler Wettkampf um ein Mittel gegen Covid-19: Die streng geheimen Fördermittel für den Coronavirus-Impfstoff
Globaler Wettkampf um ein Mittel gegen Covid-19: Die streng geheimen Fördermittel für den Coronavirus-Impfstoff

Der Tagesspiegel, Germany

21 mayo 2020

Szczepionka na koronawirusa będzie dostępna dla Polaków? Może być z tym kłopot…
Szczepionka na koronawirusa będzie dostępna dla Polaków? Może być z tym kłopot…

Newsweek Poland, Poland

28 mayo 2020

Les Etats européens sont pour l’instant incapables de garantir un accès équitable à un futur vaccin contre le Covid
Les Etats européens sont pour l’instant incapables de garantir un accès équitable à un futur vaccin contre le Covid

Basta!, France, Basta!

22 julio 2020

Ble maktesløst vitne til død – selv om vaksinen fantes
Ble maktesløst vitne til død – selv om vaksinen fantes

NRK, Norway

28 agosto 2020

Norge dropper globalt vaksinekjøp
Norge dropper globalt vaksinekjøp

NRK, Norway

28 agosto 2020

Europa stanser grep som kan skaffe mye mer covid-19-vaksine
Europa stanser grep som kan skaffe mye mer covid-19-vaksine

Stavanger Aftenblad, Norway

10 marzo 2021

Europa blochează decizia care ar extinde masiv capacitatea de producție a vaccinului anti-covid. De ce?
Europa blochează decizia care ar extinde masiv capacitatea de producție a vaccinului anti-covid. De ce?

Baricada Bulgaria, Bulgaria

19 marzo 2021

Защо ЕС блокира предложение, което ще разшири значително производството на ваксини?
Защо ЕС блокира предложение, което ще разшири значително производството на ваксини?

Baricada Bulgaria, Bulgaria

24 marzo 2021

Jak Europa lawirowała w sprawie patentów na szczepionki: wspierać USA czy Big Pharmę?
Jak Europa lawirowała w sprawie patentów na szczepionki: wspierać USA czy Big Pharmę?

Gazeta Wyborcza, Poland

10 mayo 2021

Quebra de patentes de vacinas: EUA e Espanha de um lado, Portugal e Alemanha do outro
Quebra de patentes de vacinas: EUA e Espanha de um lado, Portugal e Alemanha do outro

Público, Portugal

10 mayo 2021

Εμβόλια Covid-19: υποκρισία με (ευρωπαϊκή) πατέντα
Εμβόλια Covid-19: υποκρισία με (ευρωπαϊκή) πατέντα

EfSyn, Greece

10 mayo 2021

EU negotiators defend high Covid vaccines prices paid to pharma
EU negotiators defend high Covid vaccines prices paid to pharma

EUobserver, Belgium

23 septiembre 2021

Dyrt å få vaksiner først
Dyrt å få vaksiner først

Klassekampen, Norway

23 septiembre 2021

Colpo grosso Big Pharma: intascati 31 mld in più
Colpo grosso Big Pharma: intascati 31 mld in più

Il Fatto Quotidiano, Italy

23 septiembre 2021

A UE cedeu às exigências das farmacêuticas em negociações secretas sobre o preço das vacinas
A UE cedeu às exigências das farmacêuticas em negociações secretas sobre o preço das vacinas

Público, Portugal

23 septiembre 2021

„Diese Preise zahlen wir nicht“: Einblicke in die streng geheimen Verhandlungen zwischen EU und „Big Pharma“
„Diese Preise zahlen wir nicht“: Einblicke in die streng geheimen Verhandlungen zwischen EU und „Big Pharma“

Der Tagesspiegel, Germany

24 septiembre 2021

EU’s ‘secret’ vaccine negotiators: Who’s dealing with Big Pharma?
EU’s ‘secret’ vaccine negotiators: Who’s dealing with Big Pharma?

EUobserver, Belgium

4 noviembre 2021

Anonym im Namen der EU
Anonym im Namen der EU

taz, Germany

4 noviembre 2021

Ue, i conflitti d’interessi dei negoziatori dei vaccini
Ue, i conflitti d’interessi dei negoziatori dei vaccini

Il Fatto Quotidiano, Italy

6 noviembre 2022

Vacinas covid: quem são os negociadores secretos da UE com a indústria farmacêutica?
Vacinas covid: quem são os negociadores secretos da UE com a indústria farmacêutica?

Público, Portugal

8 noviembre 2021

Οι Μυστικοί Εφτά και ο αρχιλομπίστας της Big Pharma
Οι Μυστικοί Εφτά και ο αρχιλομπίστας της Big Pharma

EfSyn, Greece

5 abril 2022